Metabolic Imaging of Untreated Prostate Cancer by Positron Emission Tomography with sup 18 Fluorine-Labeled Deoxyglucose
- 1 March 1996
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 155 (3), 994-998
- https://doi.org/10.1016/s0022-5347(01)66366-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Quantitative Measurements of Prostatic Blood Flow and Blood Volume by Positron Emission TomographyJournal of Urology, 1992
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990
- Comparison of Magnetic Resonance Imaging and Ultrasonography in Staging Early Prostate CancerThe New England Journal of Medicine, 1990
- DNA synthesis, blood flow, and glucose utilization in experimental rat brain tumorsJournal of Neurosurgery, 1989
- PET of malignant cerebral tumors after interstitial brachytherapyJournal of Neurosurgery, 1988
- Morphometric and Clinical Studies on 68 Consecutive Radical ProstatectomiesJournal of Urology, 1988
- Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studiesAmerican Journal of Roentgenology, 1988
- Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.Radiology, 1987
- Stage D1 adenocarcinoma of prostateUrology, 1984
- Maximum Likelihood Reconstruction for Emission TomographyIEEE Transactions on Medical Imaging, 1982